Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Tugizov S, Berline J, Herrera R, Penaranda ME, Nakagawa M, Palefsky J.

J Virol. 2005 Jan;79(2):1099-112.

PMID:
15613338
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.

Firzlaff JM, Galloway DA, Eisenman RN, Lüscher B.

New Biol. 1989 Oct;1(1):44-53.

PMID:
2562189
[PubMed - indexed for MEDLINE]
3.

HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.

Massimi P, Pim D, Storey A, Banks L.

Oncogene. 1996 Jun 6;12(11):2325-30.

PMID:
8649772
[PubMed - indexed for MEDLINE]
4.

The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.

Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KH.

EMBO J. 1990 Jan;9(1):153-60.

PMID:
2153075
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.

Chien WM, Parker JN, Schmidt-Grimminger DC, Broker TR, Chow LT.

Cell Growth Differ. 2000 Aug;11(8):425-35.

PMID:
10965847
[PubMed - indexed for MEDLINE]
Free Article
6.

The E7 oncoprotein of human papillomavirus type 16 interacts with F-actin in vitro and in vivo.

Rey O, Lee S, Baluda MA, Swee J, Ackerson B, Chiu R, Park NH.

Virology. 2000 Mar 15;268(2):372-81.

PMID:
10704345
[PubMed - indexed for MEDLINE]
Free Article
7.

Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.

Genovese NJ, Banerjee NS, Broker TR, Chow LT.

J Virol. 2008 May;82(10):4862-73. doi: 10.1128/JVI.01202-07. Epub 2008 Mar 5.

PMID:
18321970
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.

Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT, Zheng JW.

Int J Oral Maxillofac Surg. 2006 Jul;35(7):653-7. Epub 2006 Feb 28.

PMID:
16513324
[PubMed - indexed for MEDLINE]
9.

Casein kinase II activities related to hyperphosphorylation of human papillomavirus type 16-E7 oncoprotein in epidermal keratinocytes.

Hashida T, Yasumoto S.

Biochem Biophys Res Commun. 1990 Oct 30;172(2):958-64.

PMID:
2173586
[PubMed - indexed for MEDLINE]
10.

Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons.

Khan MA, Tolleson WH, Gangemi JD, Pirisi L.

J Virol. 1993 Jun;67(6):3396-403.

PMID:
8388505
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation.

Eichten A, Rud DS, Grace M, Piboonniyom SO, Zacny V, Münger K.

Virology. 2004 Feb 5;319(1):81-93.

PMID:
14967490
[PubMed - indexed for MEDLINE]
Free Article
12.

Repression of p53 transcriptional activity by the HPV E7 proteins.

Massimi P, Banks L.

Virology. 1997 Jan 6;227(1):255-9.

PMID:
9007083
[PubMed - indexed for MEDLINE]
Free Article
13.

Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle.

Massimi P, Banks L.

Virology. 2000 Oct 25;276(2):388-94.

PMID:
11040129
[PubMed - indexed for MEDLINE]
Free Article
14.

Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes.

Severino A, Abbruzzese C, Manente L, Valderas AA, Mattarocci S, Federico A, Starace G, Chersi A, Mileo AM, Paggi MG.

J Cell Physiol. 2007 Jul;212(1):118-25.

PMID:
17348035
[PubMed - indexed for MEDLINE]
15.

Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.

Bernat A, Avvakumov N, Mymryk JS, Banks L.

Oncogene. 2003 Sep 11;22(39):7871-81.

PMID:
12970734
[PubMed - indexed for MEDLINE]
16.

Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.

Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY.

Reprod Sci. 2007 Jan;14(1):20-8.

PMID:
17636212
[PubMed - indexed for MEDLINE]
17.

Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics.

Lee KA, Kang JW, Shim JH, Kho CW, Park SG, Lee HG, Paik SG, Lim JS, Yoon DY.

Gynecol Oncol. 2005 Oct;99(1):142-52.

PMID:
16038965
[PubMed - indexed for MEDLINE]
18.

RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.

Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.

Apoptosis. 2008 Feb;13(2):273-81.

PMID:
18060502
[PubMed - indexed for MEDLINE]
19.

Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines.

Selvey LA, Dunn LA, Tindle RW, Park DS, Frazer IH.

J Gen Virol. 1994 Jul;75 ( Pt 7):1647-53.

PMID:
8021595
[PubMed - indexed for MEDLINE]
Free Article
20.

Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein.

Mileo AM, Piombino E, Severino A, Tritarelli A, Paggi MG, Lombardi D.

J Bioenerg Biomembr. 2006 Aug;38(3-4):215-25.

PMID:
17103045
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk